Federal Register / Vol. 85, No. 229 / Friday, November 27, 2020 / Notices 76113 

NUCLEAR REGULATORY 

COMMISSION 

Advisory Committee on the Medical 

Uses of Isotopes: Call for Nominations 

AGENCY: U.S. Nuclear Regulatory 

Commission 

ACTION: Call for nominations. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) is soliciting for 

nominations for the Patients’ Rights 

Advocate representative position on the 

Advisory Committee of the Medical 

Uses of Isotopes (ACMUI). Patients’ 

Rights Advocate nominees should have 

professional or personal experience 

with and/or knowledge about patient 

advocacy. Also, involvement or 

leadership with patient advocacy 

organizations is preferred. 

DATES: Nominations are due on or 

before January 26, 2021. 

ADDRESSES: Nomination Process: 

Submit an electronic copy of resume or 

curriculum vitae, along with a cover 

letter, to Ms. Kellee Jamerson, 

Kellee.Jamerson@nrc.gov. The cover 

letter should describe the nominee’s 

current involvement with patients’ 

rights advocacy and express the 

nominee’s interest in the position. 

Please ensure that the resume or 

curriculum vitae includes the following 

information, if applicable: Education; 

certification; professional association 

membership and committee 

membership activities; and number of 

years, timeframe, and type of setting for 

patient advocacy. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Kellee Jamerson, U.S. Nuclear 

Regulatory Commission, Office of 

Nuclear Material Safety and Safeguards; 

(301) 415–7408; Kellee.Jamerson@

nrc.gov. 

SUPPLEMENTARY INFORMATION: The 

ACMUI Patients’ Rights Advocate 

representative provides advice to the 

NRC staff on patients’ issues associated 

with the regulation of medical 

applications of byproduct material. This 

advice includes ensuring patients’ rights 

are represented during the development 

and implementation of the NRC’s 

medical-use regulations. This individual 

is appointed based on his or her 

professional and personal experience 

with and/or knowledge about patient 

advocacy, as well as involvement and/ 

or leadership with patient advocacy 

organizations. 

ACMUI members are selected based 

on their educational background, 

certification(s), work experience, 

involvement and/or leadership in 

professional society activities, and other 

information obtained from 

recommendation letters or during the 

selection process. Nominees should 

have the demonstrated ability to 

establish effective work relationships 

with peers and implement successful 

approaches to problem solving and 

conflict resolution. ACMUI members 

currently serve a four-year term and 

may be considered for reappointment to 

an additional term. The current ACMUI 

membership is comprised of the 

following professionals: (a) Nuclear 

medicine physician; (b) nuclear 

cardiologist; (c) nuclear medicine 

physicist; (d) therapy medical physicist; 

(e) radiation safety officer; (f) nuclear 

pharmacist; (g) two radiation 

oncologists; (h) patients’ rights 

advocate; (i) Food and Drug 

Administration representative; (j) 

Agreement State representative; (k) 

healthcare administrator; and (l) 

diagnostic radiologist. For additional 

information about membership on the 

ACMUI, visit the ACMUI Membership 

web page, http://www.nrc.gov/aboutnrc/regulatory/advisory/acmui/ 

membership.html. 

Nominees must be U.S. citizens and 

be able to devote up to 160 hours per 

year to ACMUI business. Members are 

expected to attend semi-annual 

meetings in Rockville, Maryland and to 

participate in teleconferences, as 

needed. Members who are not Federal 

employees are compensated for their 

service. In addition, members are 

reimbursed for travel (including per 

diem in lieu of subsistence) and are 

reimbursed secretarial and 

correspondence expenses. Full-time 

Federal employees are reimbursed for 

travel expenses only. 

Security Background Check: The 

selected nominee will undergo a 

thorough security background check. 

Security paperwork may take the 

nominee several weeks to complete. 

Nominees will also be required to 

complete a financial disclosure 

statement to avoid conflicts of interest. 

Dated: November 20, 2020. 

Russell E. Chazell, 

Advisory Committee Management Officer. 

[FR Doc. 2020–26151 Filed 11–25–20; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

[Docket Nos. 50–003, 50–247, and 50–286; 

NRC–2020–0251] 

Holtec Decommissioning International, 

LLC; 

Indian Point Nuclear Generating 

Station, Unit Nos. 1, 2, and 3 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: Exemption; issuance. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) is issuing an 

exemption in response to a February 12, 

2020, request from Holtec 

Decommissioning International, LLC 

(HDI). The exemption permits HDI to 

make withdrawals from the Indian Point 

Nuclear Generating Station, Unit Nos. 1, 

2, and 3 (referred to individually as IP1, 

IP2, and IP3, respectively, and 

collectively as the Indian Point Energy 

Center or IPEC) Decommissioning Trust 

Funds (DTFs) for spent fuel 

management and site restoration 

activities for IP1, IP2, and IP3 without 

prior notification to the NRC. This 

exemption is effective upon issuance, 

but only applies to HDI upon the 

consummation of the transfers of the 

licenses for IP1, IP2, and IP3 to Holtec 

International (Holtec) subsidiaries 

Holtec Indian Point 2, LLC and Holtec 

Indian Point 3, LLC and the transfer of 

the operating authority under the 

licenses to HDI. 

DATES: The exemption was issued on 

November 23, 2020. 

ADDRESSES: Please refer to Docket ID 

NRC–2020–0251 when contacting the 

NRC about the availability of 

information regarding this document. 

You may obtain publicly available 

information related to this document by 

any of the following methods: 

• Federal Rulemaking website: Go to 

https://www.regulations.gov and search 

for Docket ID NRC–2020–0251. Address 

questions about Docket IDs in 

Regulations.gov to Jennifer Borges; 

telephone: 301–287–9127; email: 

Jennifer.Borges@nrc.gov. For technical 

questions, contact the individual listed 

in the FOR FURTHER INFORMATION

CONTACT section of this document. 

• NRC’s Agencywide Documents 

Access and Management System 

(ADAMS): You may obtain publicly 

available documents online in the 

ADAMS Public Documents collection at 

https://www.nrc.gov/reading-rm/ 

adams.html. To begin the search, select 

‘‘Begin Web-based ADAMS Search.’’ For 

problems with ADAMS, please contact 

the NRC’s Public Document Room (PDR) 


jbell on DSKJLSW7X2PROD with NOTICES